100% tevredenheidsgarantie Direct beschikbaar na betaling Zowel online als in PDF Je zit nergens aan vast
Eerder door jou gezocht
Test Bank For Pharmacology A Patient-Centered Nursing Process Approach 11th Edition by Linda E. McCuistion | Newest Version 2023/2024 | 9780323793155 | Chapter 1-58 | Complete Questions and Answers A+€9,81
In winkelwagen
Test Bank For Pharmacology A Patient-Centered Nursing Process Approach 11th Edition by Linda E. McCuistion | Newest Version 2023/2024 | 9780323793155 | Chapter 1-58 | Complete Questions and Answers A+
192 keer bekeken 7 keer verkocht
Vak
Pharmacology
Instelling
Pharmacology
Boek
Pharmacology
Test Bank For Pharmacology A Patient-Centered Nursing Process Approach 11th Edition by Linda E. McCuistion | Newest Version 2023/2024 | 9780323793155 | Chapter 1-58 | Complete Questions and Answers A+
test bank for pharmacology a patient centered nurs
Gekoppeld boek
Titel boek:
Auteur(s):
Uitgave:
ISBN:
Druk:
Meer samenvattingen voor studieboek
Test Bank Pharmacology A Patient-Centered Nursing Process Approach, 11th Edition by Linda E. McCuistion || All Chapters || Complete Solution | Grade A+.
TEST BANK FOR PHARMACOLOGY A PATIENT-CENTERED NURSING PROCESS APPROACH, 10TH EDITION BY LINDA E. MCCUISTION (CHAPTER1- 55 ALL COVERED) ISBN: 978-0323642477
Test Bank Pharmacology and the Nursing Process 10th Edition chapter 11 Complete Guide Newest Version 2023.pdf
Alles voor dit studieboek
(150)
Geschreven voor
Pharmacology
Pharmacology
Verkoper
Volgen
Aplusplus
Ontvangen beoordelingen
Voorbeeld van de inhoud
QUESTION 1. CYCLOOXYGENASE (COX-1, COX-2) Cyclooxygenase, an enzyme important for prostaglandin formation, abbreviated COX, has a form that we colloquially refer to as good COX and bad COX. Which cyclooxygenase is the “bad COX?” a) COX -1 b) COX -2 c) COX -3 d) COX -4 Answer B. Inhibiting or blocking COX -1, the good COX, can result in bad things: gastric erosion and ulcers, kidney impairment and bleeding. Suppresssing COX -2, the bad COX, can result in good things like suppressing inflammation, reducing pain and fever, and protecting against colon cancer. QUESTION 2. RESULTS OF BLOCKING COX -2 Drugs like ibuprofen, naproxen, and meloxicam affect cyclooxygenase. When we have inhibition of cyclooxygenase -2 (COX -2) we might expect all of the following except: a) Analgesia and antipyresis b) Colorectal cancer protection c) Gastric ulcers d) Suppressed inflammation C, Gastric ulcers. A gastric ulcer would likely result from blocking the good COX, COX -1. However, if we block COX -2, the bad COX, we get analgesia (pain reduction), antipyresis (fever reduction), colorectal cancer protection, and suppressed inflammation. QUESTION 3: IBUPROFEN VS ACETAMINOPHEN Often patients ask the difference between ibuprofen and acetaminophen. Acetaminophen and ibuprofen share all of the following therapeutic effects except: a) Analgesia b) b) Antiinflammatory c) c) Antipyresis d) d) Pain relief B, anti-inflammatory. While acetaminophen and ibuprofen can provide pain relief (analgesia) and fever reduction (antipyresis), only ibuprofen can provide anti -inflammatory effects. So we have two basic branches, the drug that can’t affect inflammation and the one that can. QUESTION 4. THE CELECOXIB ADVANTAGE 4) What was thought of as a breakthrough was a selective cyclooxygenase inhibitor that might reduce GI distress from NSAID use. An arthritic patient with a history of GI distress and bleed might be a candidate for: a) Celecoxib b) Ibuprofen c) Naproxen ) Meloxicam A, celecoxib. Celecoxib was meant to protect against GI distress, but cardiac issues came up as patients took it reducing its utilization. Ibuprofen, naproxen, and meloxicam would likely eventually cause GI distress. QUESTION 5. THE DAILY ASPIRIN ISSUE In pharmacology, the best practice in using a medication can change even with the most common medicines. What concern about daily aspirin led to a change in the way prescribers look at it for protecting against cardiac events? a) Bleed risk that can outweigh protective benefit b) No longer suppresses platelet aggregation c) No longer protects against MI d) No longer protects against stroke A, Bleed risk that can outweigh protective benefit. While aspirin still suppresses platelet aggregation and can work to prevent MI and stroke in patients, the bleed risk is a concern. The new guidelines don’t apply to those who had a stroke/heart attack, underwent bypass surgery or had a stend procedure. These new guidelines apply to otherwise healthy adults and elderly with a high internal bleed risk.
Voordelen van het kopen van samenvattingen bij Stuvia op een rij:
Verzekerd van kwaliteit door reviews
Stuvia-klanten hebben meer dan 700.000 samenvattingen beoordeeld. Zo weet je zeker dat je de beste documenten koopt!
Snel en makkelijk kopen
Je betaalt supersnel en eenmalig met iDeal, creditcard of Stuvia-tegoed voor de samenvatting. Zonder lidmaatschap.
Focus op de essentie
Samenvattingen worden geschreven voor en door anderen. Daarom zijn de samenvattingen altijd betrouwbaar en actueel. Zo kom je snel tot de kern!
Veelgestelde vragen
Wat krijg ik als ik dit document koop?
Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.
Tevredenheidsgarantie: hoe werkt dat?
Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.
Van wie koop ik deze samenvatting?
Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper Aplusplus. Stuvia faciliteert de betaling aan de verkoper.
Zit ik meteen vast aan een abonnement?
Nee, je koopt alleen deze samenvatting voor €9,81. Je zit daarna nergens aan vast.
